Ashwagandha (Withania somnifera) has been used for more than 3,000 years in Ayurvedic medicine as a rasayana, a tonic for vitality and longevity. But in the world of modern nutraceuticals, not all ashwagandha extracts are equivalent. The standardized root powder labelled "5% withanolides" that you find in supermarkets has little in common with what scientific science has actually validated. And what science has validated is, primarily, one specific extract: KSM-66.
As a micronutrition specialist, I see ashwagandha being recommended generically, with no consideration for the galenic form, dosage, duration of use or the individual's profile. This article gives you the actual scientific data so you can understand what this adaptogen does in your biology, and how to get the most out of it.
What exactly is KSM-66?
KSM-66 is a patented ashwagandha root extract developed by Ixoreal Biomed, standardized to a minimum of 5% withanolides (measured by HPLC) and, more importantly, obtained through a unique extraction process that preserves the full spectrum of the root's active compounds, withanolides, withaferins, sitoindosides, and the plant's specific oligosaccharides, without using alcoholic solvents. It is currently the most scientifically studied extract, with more than 24 published randomized controlled trials.
The distinction between KSM-66 and a generic extract is not marketing, it is a question of phytochemistry. The bioactivity of an adaptogenic plant depends on the synergy between its multiple active components, not a single isolated marker. An extract standardized only on withanolides may have stripped out the cofactors needed for their activity.
Mechanisms of action: how it works
Ashwagandha acts on the HPA axis (hypothalamic-pituitary-adrenal) through several complementary mechanisms:
- Inhibition of cortisol secretion: withanolides interfere with CRH (corticotropin-releasing hormone) signaling at the hypothalamic level and modulate the activity of 11β-HSD1 (the enzyme that converts cortisone to cortisol at the tissue level)
- GABAergic modulation: glycowithanolides bind to GABA-A receptors with moderate affinity, producing an anxiolytic effect without sedation or dependence
- Inhibition of NF-κB: reduction in the transcription of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), which are both cause and consequence of chronic stress
- Support of BDNF production: withanolides A and B increase the expression of the neurotrophic factor BDNF, supporting hippocampal neurogenesis and cognitive plasticity
What the scientific trials say
Here is the most robust scientific data on KSM-66:
The Choudhary et al. study (2017, Journal of Dietary Supplements) on 50 adults showed significant improvement in immediate memory, working memory and information processing speed after 8 weeks of KSM-66 at 300 mg twice daily. The authors attribute these effects to reduced cerebral oxidative stress and increased BDNF.
Dosage, timing and precautions
Scientifically validated dosage
The dose that has demonstrated efficacy in the majority of trials is 300 mg of KSM-66 twice daily (i.e. 600 mg/day), taken with meals to optimize the bioavailability of the (fat-soluble) withanolides. Effects are observed at 300 mg/day, but the most robust responses are obtained at 600 mg/day.
Timing and duration
- Stress/cortisol goal: 1 dose in the morning (to blunt the morning cortisol peak) + 1 dose in early evening
- Sleep goal: single dose of 300–600 mg at bedtime
- Minimum recommended duration: 8 weeks to evaluate effects. Benefits on stress and sleep are generally noticeable from 2 to 4 weeks.
- Cycling: after 12 continuous weeks, a 4-week pause is recommended to maintain sensitivity to withanolides
Precautions and contraindications
Ashwagandha is contraindicated in pregnancy (documented uterotonic effect), in hyperthyroidism (it potentiates thyroid activity and can exacerbate thyrotoxicosis), and should be used with caution in people taking immunosuppressants (immunostimulant effect) or sedatives (possible potentiation). A baseline thyroid panel is recommended before any prolonged supplementation.
Ashwagandha KSM-66 is part of my first-line protocol for profiles with chronic stress, elevated evening cortisol, difficulty falling asleep and inadequate recovery. I systematically combine it with magnesium bisglycinate (GABAergic synergy) and with phosphatidylserine in cases of documented morning hypercortisolemia. Assessment via salivary cortisol at T0 and T8 weeks.